Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells

Katsuya Hirano, Namie Nomoto, Mayumi Hirano, Fumi Momota, Akiko Hanada, Hideo Kanaide

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Proteinase-activated receptors 1 and 4 (PAR1 and PAR 4) are the major receptors mediating thrombin-induced NO production in endothelial cells. The intracellular signaling following their activation still remains to be elucidated. The present study provides the first evidence for the distinct Ca2+ requirement for the NO production between PAR1 and PAR4. The activation of PAR1 by the activating peptide (PAR1-AP) elevated cytosolic Ca2+ concentrations ([Ca2+]i) and activated NO production in porcine aortic and human umbilical vein endothelial cells, whereas it had little effect on bovine aortic endothelial cells. PAR4 activation by PAR4-AP consistently induced NO production without an appreciable [Ca2+]i elevation in three types of endothelial cells. The PAR1-mediated NO production was significantly inhibited by 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA), whereas the PAR4-mediated NO production was resistant. NO production following the PAR1 and PAR4 activation was significantly inhibited by pertussis toxin, but it was resistant to a Gαq/11 inhibitor, YM254890 [(1R)-1-{(3S,6S,9S,12S,18R,21S,22R)-21-acetamido-18-benzyl- 3-[(1R)-1-methoxyethyl]-4,9,10,12,16,22-hexamethyl-15-methylene-2,5,8,11,14,17, 20-heptaoxo-1,19-dioxa-4,7,10,13,16-pentaazacyclodocosan-6-yl}-2-methylpropyl rel-(2S,3R)-2-acetamido-3-hydroxy-4-methylpentanoate]. However, YM254890 abrogated the PAR1-mediated Ca2+ signal. PAR 4-mediated NO production was substantially inhibited by the inhibitors of phosphotidylinositol-3 kinase (PI3K) and Akt, as well as by the dominant negative mutant of Akt. The PAR1-mediated NO production was relatively resistant to inhibitors of PI3K. An immunoblot analysis revealed a transient increase in the phosphorylation of Akt and endothelial NO synthase following the PAR4 stimulation. In conclusion, PAR1 and PAR4 engage distinct signal transduction mechanisms to activate NO production in vascular endothelial cells. PAR4 preferably activates Gαi/o and induced NO production in a manner mostly independent of Ca2+ but dependent on the PI3K/Akt pathway, whereas PAR 1 activates both the Ca2+-dependent and -independent mechanisms.

Original languageEnglish
Pages (from-to)668-677
Number of pages10
JournalJournal of Pharmacology and Experimental Therapeutics
Volume322
Issue number2
DOIs
Publication statusPublished - Aug 1 2007

Fingerprint

PAR-1 Receptor
Endothelial Cells
Phosphotransferases
Thrombin Receptors
Ethane
Pertussis Toxin
Human Umbilical Vein Endothelial Cells
Nitric Oxide Synthase
Signal Transduction
Swine
Phosphorylation
Peptides
Acids
YM-254890

All Science Journal Classification (ASJC) codes

  • Molecular Medicine
  • Pharmacology

Cite this

Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells. / Hirano, Katsuya; Nomoto, Namie; Hirano, Mayumi; Momota, Fumi; Hanada, Akiko; Kanaide, Hideo.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 322, No. 2, 01.08.2007, p. 668-677.

Research output: Contribution to journalArticle

@article{2d2b316161fe45258ac1891e758ec5a6,
title = "Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells",
abstract = "Proteinase-activated receptors 1 and 4 (PAR1 and PAR 4) are the major receptors mediating thrombin-induced NO production in endothelial cells. The intracellular signaling following their activation still remains to be elucidated. The present study provides the first evidence for the distinct Ca2+ requirement for the NO production between PAR1 and PAR4. The activation of PAR1 by the activating peptide (PAR1-AP) elevated cytosolic Ca2+ concentrations ([Ca2+]i) and activated NO production in porcine aortic and human umbilical vein endothelial cells, whereas it had little effect on bovine aortic endothelial cells. PAR4 activation by PAR4-AP consistently induced NO production without an appreciable [Ca2+]i elevation in three types of endothelial cells. The PAR1-mediated NO production was significantly inhibited by 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA), whereas the PAR4-mediated NO production was resistant. NO production following the PAR1 and PAR4 activation was significantly inhibited by pertussis toxin, but it was resistant to a Gαq/11 inhibitor, YM254890 [(1R)-1-{(3S,6S,9S,12S,18R,21S,22R)-21-acetamido-18-benzyl- 3-[(1R)-1-methoxyethyl]-4,9,10,12,16,22-hexamethyl-15-methylene-2,5,8,11,14,17, 20-heptaoxo-1,19-dioxa-4,7,10,13,16-pentaazacyclodocosan-6-yl}-2-methylpropyl rel-(2S,3R)-2-acetamido-3-hydroxy-4-methylpentanoate]. However, YM254890 abrogated the PAR1-mediated Ca2+ signal. PAR 4-mediated NO production was substantially inhibited by the inhibitors of phosphotidylinositol-3 kinase (PI3K) and Akt, as well as by the dominant negative mutant of Akt. The PAR1-mediated NO production was relatively resistant to inhibitors of PI3K. An immunoblot analysis revealed a transient increase in the phosphorylation of Akt and endothelial NO synthase following the PAR4 stimulation. In conclusion, PAR1 and PAR4 engage distinct signal transduction mechanisms to activate NO production in vascular endothelial cells. PAR4 preferably activates Gαi/o and induced NO production in a manner mostly independent of Ca2+ but dependent on the PI3K/Akt pathway, whereas PAR 1 activates both the Ca2+-dependent and -independent mechanisms.",
author = "Katsuya Hirano and Namie Nomoto and Mayumi Hirano and Fumi Momota and Akiko Hanada and Hideo Kanaide",
year = "2007",
month = "8",
day = "1",
doi = "10.1124/jpet.107.121038",
language = "English",
volume = "322",
pages = "668--677",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "2",

}

TY - JOUR

T1 - Distinct Ca2+ requirement for NO production between proteinase-activated receptor 1 and 4 (PAR1 and PAR4) in vascular endothelial cells

AU - Hirano, Katsuya

AU - Nomoto, Namie

AU - Hirano, Mayumi

AU - Momota, Fumi

AU - Hanada, Akiko

AU - Kanaide, Hideo

PY - 2007/8/1

Y1 - 2007/8/1

N2 - Proteinase-activated receptors 1 and 4 (PAR1 and PAR 4) are the major receptors mediating thrombin-induced NO production in endothelial cells. The intracellular signaling following their activation still remains to be elucidated. The present study provides the first evidence for the distinct Ca2+ requirement for the NO production between PAR1 and PAR4. The activation of PAR1 by the activating peptide (PAR1-AP) elevated cytosolic Ca2+ concentrations ([Ca2+]i) and activated NO production in porcine aortic and human umbilical vein endothelial cells, whereas it had little effect on bovine aortic endothelial cells. PAR4 activation by PAR4-AP consistently induced NO production without an appreciable [Ca2+]i elevation in three types of endothelial cells. The PAR1-mediated NO production was significantly inhibited by 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA), whereas the PAR4-mediated NO production was resistant. NO production following the PAR1 and PAR4 activation was significantly inhibited by pertussis toxin, but it was resistant to a Gαq/11 inhibitor, YM254890 [(1R)-1-{(3S,6S,9S,12S,18R,21S,22R)-21-acetamido-18-benzyl- 3-[(1R)-1-methoxyethyl]-4,9,10,12,16,22-hexamethyl-15-methylene-2,5,8,11,14,17, 20-heptaoxo-1,19-dioxa-4,7,10,13,16-pentaazacyclodocosan-6-yl}-2-methylpropyl rel-(2S,3R)-2-acetamido-3-hydroxy-4-methylpentanoate]. However, YM254890 abrogated the PAR1-mediated Ca2+ signal. PAR 4-mediated NO production was substantially inhibited by the inhibitors of phosphotidylinositol-3 kinase (PI3K) and Akt, as well as by the dominant negative mutant of Akt. The PAR1-mediated NO production was relatively resistant to inhibitors of PI3K. An immunoblot analysis revealed a transient increase in the phosphorylation of Akt and endothelial NO synthase following the PAR4 stimulation. In conclusion, PAR1 and PAR4 engage distinct signal transduction mechanisms to activate NO production in vascular endothelial cells. PAR4 preferably activates Gαi/o and induced NO production in a manner mostly independent of Ca2+ but dependent on the PI3K/Akt pathway, whereas PAR 1 activates both the Ca2+-dependent and -independent mechanisms.

AB - Proteinase-activated receptors 1 and 4 (PAR1 and PAR 4) are the major receptors mediating thrombin-induced NO production in endothelial cells. The intracellular signaling following their activation still remains to be elucidated. The present study provides the first evidence for the distinct Ca2+ requirement for the NO production between PAR1 and PAR4. The activation of PAR1 by the activating peptide (PAR1-AP) elevated cytosolic Ca2+ concentrations ([Ca2+]i) and activated NO production in porcine aortic and human umbilical vein endothelial cells, whereas it had little effect on bovine aortic endothelial cells. PAR4 activation by PAR4-AP consistently induced NO production without an appreciable [Ca2+]i elevation in three types of endothelial cells. The PAR1-mediated NO production was significantly inhibited by 1,2-bis(2-aminophenoxy)ethane-N,N,N′,N′-tetraacetic acid (BAPTA), whereas the PAR4-mediated NO production was resistant. NO production following the PAR1 and PAR4 activation was significantly inhibited by pertussis toxin, but it was resistant to a Gαq/11 inhibitor, YM254890 [(1R)-1-{(3S,6S,9S,12S,18R,21S,22R)-21-acetamido-18-benzyl- 3-[(1R)-1-methoxyethyl]-4,9,10,12,16,22-hexamethyl-15-methylene-2,5,8,11,14,17, 20-heptaoxo-1,19-dioxa-4,7,10,13,16-pentaazacyclodocosan-6-yl}-2-methylpropyl rel-(2S,3R)-2-acetamido-3-hydroxy-4-methylpentanoate]. However, YM254890 abrogated the PAR1-mediated Ca2+ signal. PAR 4-mediated NO production was substantially inhibited by the inhibitors of phosphotidylinositol-3 kinase (PI3K) and Akt, as well as by the dominant negative mutant of Akt. The PAR1-mediated NO production was relatively resistant to inhibitors of PI3K. An immunoblot analysis revealed a transient increase in the phosphorylation of Akt and endothelial NO synthase following the PAR4 stimulation. In conclusion, PAR1 and PAR4 engage distinct signal transduction mechanisms to activate NO production in vascular endothelial cells. PAR4 preferably activates Gαi/o and induced NO production in a manner mostly independent of Ca2+ but dependent on the PI3K/Akt pathway, whereas PAR 1 activates both the Ca2+-dependent and -independent mechanisms.

UR - http://www.scopus.com/inward/record.url?scp=34547109096&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547109096&partnerID=8YFLogxK

U2 - 10.1124/jpet.107.121038

DO - 10.1124/jpet.107.121038

M3 - Article

C2 - 17494865

AN - SCOPUS:34547109096

VL - 322

SP - 668

EP - 677

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 2

ER -